United States

Jazz Pharmaceuticals PLC (JAZZ.OQ)

JAZZ.OQ on NASDAQ Stock Exchange Global Select Market

5 Dec 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Nov 8 2016

BRIEF-Jazz Pharmaceuticals posts Q3 adj. earnings $2.57/shr

* Jazz Pharmaceuticals announces third quarter 2016 financial results

BRIEF-Jazz pharmaceuticals plc - initiates rolling nda submission

* Expects to complete submission of NDA by early 2017, and will request a priority review.

BRIEF-Jazz Pharma Q2 adjusted earnings per share $2.63

* Jazz pharmaceuticals announces second quarter 2016 financial results

BRIEF-Jazz Pharmaceuticals says majority of Celator's outstanding shares has been validly tendered

* Tender offer is being effected by Jazz Pharmaceuticals' indirect wholly-owned subsidiary, Plex Merger Sub

BRIEF-Jazz Pharma presents data from study for treatment for excessive sleepiness

* Presents new data from a human abuse liability study for JZP-110, an investigational treatment for excessive sleepiness in patients with narcolepsy or with OBSTR

Select another date: